Your browser doesn't support javascript.
loading
Anti-tumoral effects of somatostatin analogs: a lesson from the CLARINET study.
Albertelli, M; Nazzari, E; Sciallero, S; Grillo, F; Morbelli, S; De Cian, F; Cittadini, G; Ambrosetti, E; Ciarmiello, A; Ferone, D.
Afiliación
  • Albertelli M; Endocrinology Unit, Department of Internal Medicine (DiMI), University of Genova, Genoa, Italy.
  • Nazzari E; Endocrinology Unit, Department of Internal Medicine (DiMI), University of Genova, Genoa, Italy.
  • Sciallero S; Medical Oncology Unit, IRCCS Policlinico San Martino, Genoa, Italy.
  • Grillo F; Pathology unit, Department of Health Science (DiSSAL), University of Genova, Genoa, Italy.
  • Morbelli S; Nuclear Medicine Unit, Department of Health Science (DiSSAL), University of Genova, Genoa, Italy.
  • De Cian F; Oncologic Surgery Unit, Department of Surgical Sciences and Integrated Diagnostics (DISC), University of Genova, Genoa, Italy.
  • Cittadini G; Department of Radiology, IRCCS Policlinico San Martino, Genoa, Italy.
  • Ambrosetti E; Endocrinology Unit, Department of Internal Medicine (DiMI), University of Genova, Genoa, Italy.
  • Ciarmiello A; Department of Nuclear Medicine, S. Andrea Hospital, La Spezia, Italy.
  • Ferone D; Endocrinology Unit, Department of Internal Medicine (DiMI), University of Genova, Genoa, Italy. ferone@unige.it.
J Endocrinol Invest ; 40(11): 1265-1269, 2017 Nov.
Article en En | MEDLINE | ID: mdl-28550464

Texto completo: 1 Colección: 01-internacional Asunto principal: Somatostatina / Tumores Neuroendocrinos / Antineoplásicos Tipo de estudio: Guideline Límite: Humans Idioma: En Revista: J Endocrinol Invest Año: 2017 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Colección: 01-internacional Asunto principal: Somatostatina / Tumores Neuroendocrinos / Antineoplásicos Tipo de estudio: Guideline Límite: Humans Idioma: En Revista: J Endocrinol Invest Año: 2017 Tipo del documento: Article País de afiliación: Italia